Arcadia Biosciences, Inc.
RKDA
$3.46
$0.20196.21%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 49.66% | 62.09% | 56.73% | 65.37% | 9.07% |
| Total Depreciation and Amortization | -22.26% | -21.99% | -18.41% | -25.27% | -27.81% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -257.56% | -336.67% | -649.27% | -189.83% | 1,576.83% |
| Change in Net Operating Assets | 58.78% | -112.98% | -742.39% | -556.11% | -3,072.88% |
| Cash from Operations | 37.05% | 14.38% | 9.26% | -19.75% | -9.42% |
| Capital Expenditure | -220.00% | 48.39% | 48.39% | 43.75% | 93.06% |
| Sale of Property, Plant, and Equipment | 190.43% | 538.46% | 106.90% | -37.42% | -87.50% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 257.70% | 207.98% | 215.94% | -654.92% | -882.78% |
| Cash from Investing | 269.01% | 218.57% | 224.48% | -572.59% | -406.56% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.85% | -99.85% | -99.89% | -99.89% | 20.01% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 100.00% | 100.00% | -1.84% |
| Cash from Financing | -99.84% | -99.84% | -99.88% | -99.88% | 21.97% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 83.89% | 44.87% | -2.97% | -1,167.29% | -75.67% |